BLSM BlossomHill Therapeutics, Inc.
$20.86▼ -3.02%
Healthcare
Other
After hours
$21.27▲ +1.97%
Sep 11, 7:30 PM ET
Volume 148.9K
Avg Volume (10D) 140.9K
Key Metrics & Fundamentals
Market Cap
$606.63M
P/E Ratio
–
Div Yield
–%
52W Range
15.25 - 23.37
% vs 50 MA
–%
% vs 200 MA
–%
RSI-14
67.8
Free Cash Flow
-$20.95M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$21.98M
COGS
–
Operating Exp
$22.11M
Operating Income
-$22.11M
EBIT
-$22.11M
Pretax Income
-$21.01M
Net Income
-$21.01M
EPS (Diluted)
-0.72
Price & Volume History
Loading chart…
Recent News
BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 11:00 AM
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Cancer
GlobeNewswire · Sep 1, 2026 11:00 AM
Insiders Are Betting Big on These 3 Healthcare Stocks
MarketBeat · Aug 31, 2026 5:20 PM
Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday
MT Newswires · Aug 18, 2026 1:17 PM
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
GlobeNewswire · Aug 18, 2026 11:00 AM
BlossomHill Therapeutics Announces Pricing of Upsized $150 Million Initial Public Offering
GlobeNewswire · Aug 7, 2026 12:07 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BLSM's money flow as a full page
Social Sentiment
No Reddit posts found for BLSM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.